back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-05-20 21:07 Tx date 2021-05-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,878
+5,144 vol $3.67 each |
77,942 | |
| Filed 2021-05-20 21:06 Tx date 2021-05-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,878.48
-5,144 vol $3.67 each |
80,771 | |
| Filed 2021-05-20 21:05 Tx date 2021-05-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,772
+1,028 vol $3.67 each |
72,798 | |
| Filed 2021-05-20 21:04 Tx date 2021-05-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,772.76
-1,028 vol $3.67 each |
85,915 | |
| Filed 2021-05-20 21:03 Tx date 2021-05-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,960
+2,057 vol $3.87 each |
71,770 | |
| Filed 2021-05-20 21:02 Tx date 2021-05-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,960.59
-2,057 vol $3.87 each |
86,943 | |
| Filed 2020-10-29 17:06 Tx date 2020-10-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-38,477.12
-10,288 vol $3.74 each |
69,713 | |
| Filed 2020-10-29 16:57 Tx date 2020-10-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,238
+5,144 vol $3.74 each |
80,001 | |
| Filed 2020-10-29 16:56 Tx date 2020-10-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,238.56
-5,144 vol $3.74 each |
89,000 | |
| Filed 2020-10-29 16:55 Tx date 2020-10-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,238
+5,144 vol $3.74 each |
74,857 | |
| Filed 2020-10-29 16:54 Tx date 2020-10-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,238.56
-5,144 vol $3.74 each |
94,144 | |
| Filed 2020-06-10 18:58 Tx date 2020-06-09 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,238
+5,144 vol $3.74 each |
69,713 | |
| Filed 2020-06-10 18:57 Tx date 2020-06-09 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,238.56
-5,144 vol $3.74 each |
99,288 | |
| Filed 2020-06-02 20:07 Tx date 2020-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$131,100
+10,000 vol $13.11 each |
104,432 | |
| Filed 2019-11-22 16:20 Tx date 2019-11-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,693.18
-2,057 vol $3.74 each |
94,432 | |
| Filed 2019-11-22 16:17 Tx date 2019-11-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-7,693.18
-2,057 vol $3.74 each |
64,569 | |
| Filed 2019-11-22 16:16 Tx date 2019-11-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,693
+2,057 vol $3.74 each |
66,626 | |
| Filed 2019-11-22 16:12 Tx date 2019-11-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,238.56
-5,144 vol $3.74 each |
96,489 | |
| Filed 2019-11-22 16:10 Tx date 2019-11-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-19,238.56
-5,144 vol $3.74 each |
64,569 | |
| Filed 2019-11-22 16:08 Tx date 2019-11-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,238
+5,144 vol $3.74 each |
69,713 | |
| Filed 2019-09-19 14:05 Tx date 2019-09-16 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$141,600
+15,000 vol $9.44 each |
101,633 | |
| Filed 2019-05-22 20:34 Tx date 2019-05-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,693.18
-2,057 vol $3.74 each |
86,633 | |
| Filed 2019-05-22 20:31 Tx date 2019-05-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,693
+2,057 vol $3.74 each |
64,569 | |
| Filed 2018-12-26 Tx date 2018-12-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-5,000 vol |
62,512 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,144 vol |
88,690 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$46,170
+12,345 vol $3.74 each |
67,512 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,144 vol |
95,891 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-2,057 vol |
93,834 | |
| Filed 2018-06-05 Tx date 2018-06-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+15,000 vol $6.20 each |
101,035 | |
| Filed 2018-01-04 Tx date 2018-01-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,583 vol |
86,035 | |
| Filed 2017-06-20 Tx date 2017-06-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-3,844.72
-1,028 vol $3.74 each |
55,167 | |
| Filed 2017-06-20 Tx date 2017-06-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,844
+1,028 vol $3.74 each |
56,195 | |
| Filed 2017-06-20 Tx date 2017-06-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,844.72
-1,028 vol $3.74 each |
92,618 | |
| Filed 2017-06-02 Tx date 2017-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,475
+3,500 vol $3.85 each |
92,396 | |
| Filed 2017-06-02 Tx date 2017-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,812
+1,250 vol $3.85 each |
93,646 | |
| Filed 2017-01-27 Tx date 2017-01-26 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-7,201 vol |
55,167 | |
| Filed 2016-12-13 Tx date 2016-12-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-53,867.22
-14,403 vol $3.74 each |
88,896 | |
| Filed 2016-12-13 Tx date 2016-12-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-26,935.48
-7,202 vol $3.74 each |
62,368 | |
| Filed 2016-12-13 Tx date 2016-12-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,931
+7,201 vol $3.74 each |
62,368 | |
| Filed 2016-12-13 Tx date 2016-12-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,935
+7,202 vol $3.74 each |
69,570 | |
| Filed 2016-06-03 Tx date 2016-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,225
+1,250 vol $7.38 each |
103,299 | |
| Filed 2016-06-03 Tx date 2016-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,830
+3,500 vol $7.38 each |
102,049 | |
| Filed 2016-04-29 Tx date 2016-04-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
47 - Acquisition or disposition by gift
|
$-5,770.82
-1,543 vol $3.74 each |
98,549 | |
| Filed 2015-11-06 Tx date 2015-11-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
47 - Acquisition or disposition by gift
|
$-30,598.87
-5,041 vol $6.07 each |
100,092 | |
| Filed 2015-06-19 Tx date 2015-06-17 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,366.01
-1,543 vol $6.07 each |
105,133 | |
| Filed 2015-06-19 Tx date 2015-06-17 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,366
+1,543 vol $6.07 each |
55,167 | |
| Filed 2015-05-07 Tx date 2015-05-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,028 vol |
106,676 | |
| Filed 2015-05-07 Tx date 2015-05-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Tarnow, Michael M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,086 vol |
105,648 |